Isabelle Berrebi-Bertrand

This inventor holds 11 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Bioprojet, Sun Pharma Advanced Research Company Limited, Bioproject. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabelle Berrebi-Bertrand. Retrieved from https://idiyas.com/inventor/isabelle-berrebi-bertrand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 2)

% Patents Active = 81.8

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 13)

Average Co-Inventor Count = 10.4

ph-index = 2

Forward Citations = 31(Granted Patents)

Company Filing History:

Sun Pharma Advanced Research Company Limited

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582648 - Method for treating central nervous system disorders using dopamine D3 partial agonists (2026-03-24),

2. 12134608 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2024-11-05),

3. 11306069 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2022-04-19),

4. 9266867 - Piperidinyl monocarboxylic acids as S1P1 receptor agonists (2016-02-23),

5. 9255101 - 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands (2016-02-09),

6. 9242959 - (Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications (2016-01-26),

7. 9029357 - Benzazole derivatives as histamine H4 receptor ligands (2015-05-12),

8. 8809539 - Dicarboxylic acid derivatives as S1P1 receptor agonists (2014-08-19),

9. 8802678 - [object Object] (2014-08-12),

10. 8802664 - Benzazole derivatives as histamine H4 receptor ligands (2014-08-12),

11. 7432269 - Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents (2008-10-07),

Title: The Innovative Contributions of Isabelle Berrebi-Bertrand

Introduction

Isabelle Berrebi-Bertrand is a prominent inventor based in Pace, France. She has made significant contributions to the field of pharmaceuticals, particularly through her work on benzimidazole derivatives. With a total of 10 patents to her name, her innovations have the potential to impact therapeutic applications significantly.

Latest Patents

Her latest patents focus on benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands. The present applications concern novel benzimidazole enantiomeric derivatives, their process of preparation, and their therapeutic uses as dual H1 and H4 receptor ligands. These innovations highlight her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Isabelle has worked with notable companies such as Bioprojet and Sun Pharma Advanced Research Company Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to the advancement of pharmaceutical research.

Collaborations

Isabelle has collaborated with esteemed colleagues, including Marc Capet and Jeanne-Marie Lecomte. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Isabelle Berrebi-Bertrand's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations continue to pave the way for future advancements in medical therapies.

Profile summary based on public USPTO records.